Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Vishwajit L. Nimgaonkar is active.

Publication


Featured researches published by Vishwajit L. Nimgaonkar.


Bipolar Disorders | 2009

Association study of 21 circadian genes with bipolar I disorder, schizoaffective disorder, and schizophrenia

Hader Mansour; Michael E. Talkowski; Joel Wood; Kodavali V. Chowdari; Lora McClain; Konasale M. Prasad; Debra M. Montrose; Andrea Fagiolini; Edward S. Friedman; Michael H. Allen; Charles L. Bowden; Joseph R. Calabrese; Rif S. El-Mallakh; Michael A. Escamilla; Stephen V. Faraone; Mark D. Fossey; Laszlo Gyulai; Jennifer M. Loftis; Peter Hauser; Terence A. Ketter; Lauren B. Marangell; David J. Miklowitz; Andrew A. Nierenberg; Jayendra K. Patel; Gary S. Sachs; Pamela Sklar; Jordan W. Smoller; Nan M. Laird; Matcheri S. Keshavan; Michael E. Thase

OBJECTIVEnPublished studies suggest associations between circadian gene polymorphisms and bipolar I disorder (BPI), as well as schizoaffective disorder (SZA) and schizophrenia (SZ). The results are plausible, based on prior studies of circadian abnormalities. As replications have not been attempted uniformly, we evaluated representative, common polymorphisms in all three disorders.nnnMETHODSnWe assayed 276 publicly available tag single nucleotide polymorphisms (SNPs) at 21 circadian genes among 523 patients with BPI, 527 patients with SZ/SZA, and 477 screened adult controls. Detected associations were evaluated in relation to two published genome-wide association studies (GWAS).nnnRESULTSnUsing gene-based tests, suggestive associations were noted between EGR3 and BPI (p = 0.017), and between NPAS2 and SZ/SZA (p = 0.034). Three SNPs were associated with both sets of disorders (NPAS2: rs13025524 and rs11123857; RORB: rs10491929; p < 0.05). None of the associations remained significant following corrections for multiple comparisons. Approximately 15% of the analyzed SNPs overlapped with an independent study that conducted GWAS for BPI; suggestive overlap between the GWAS analyses and ours was noted at ARNTL.nnnCONCLUSIONSnSeveral suggestive, novel associations were detected with circadian genes and BPI and SZ/SZA, but the present analyses do not support associations with common polymorphisms that confer risk with odds ratios greater than 1.5. Additional analyses using adequately powered samples are warranted to further evaluate these results.


Molecular Psychiatry | 2005

Genetic polymorphisms of the RGS4 and dorsolateral prefrontal cortex morphometry among first episode schizophrenia patients

Konasale M. Prasad; Kodavali V. Chowdari; Vishwajit L. Nimgaonkar; Michael E. Talkowski; David A. Lewis; Matcheri S. Keshavan

Polymorphisms of the gene encoding the regulator of G-protein signaling subtype 4 (RGS4) may confer risk for schizophrenia.1 DNA microarray studies of postmortem brain samples have shown RGS4 underexpression in the dorsolateral prefrontal cortex (DLPFC, area 9), motor and visual cortices in schizophrenia patients relative to control subjects.2 Underexpression of RGS4 in DLPFC is pathophysiologically significant because DLPFC pathology in schizophrenia has been supported by neurocognitive,3,4 structural5 and functional6,7 imaging, postmortem,8 cellular9,10 and molecular11 pathological studies. For these reasons, we examined the association of DLPFC gray matter volume with RGS4 polymorphisms in a series of antipsychotic-naïve first-episode schizophrenia patients and control subjects. We hypothesized that volumetric alterations of the DLPFC would be associated with RGS4 polymorphisms and that these differences would be more pronounced in patients than in controls. We observed robust volumetric differences across the genotypes in the pooled sample of patients and control subjects; when separately analyzed, we observed differences within the patient group (n=30) but not in control subject (n=27) group. The findings suggest that RGS4 polymorphisms may contribute to structural alterations in the DLPFC.


Biological Psychiatry | 2006

Evaluation of a Susceptibility Gene for Schizophrenia: Genotype Based Meta-Analysis of RGS4 Polymorphisms from Thirteen Independent Samples

Michael E. Talkowski; Howard Seltman; Anne S. Bassett; Linda M. Brzustowicz; Xiangning Chen; Kodavali V. Chowdari; David A. Collier; Quirino Cordeiro; Aiden Corvin; Smita N. Deshpande; Michael F. Egan; Michael Gill; Kenneth S. Kendler; George Kirov; Leonard L. Heston; Pat Levitt; David A. Lewis; Tao Li; Karoly Mirnics; Derek W. Morris; Nadine Norton; Michael Conlon O'Donovan; Michael John Owen; Christian Richard; Prachi Semwal; Janet L. Sobell; David St Clair; Richard E. Straub; B.K. Thelma; Homero Vallada

BACKGROUNDnAssociations between schizophrenia (SCZ) and polymorphisms at the regulator of G-protein signaling 4 (RGS4) gene have been reported (single nucleotide polymorphisms [SNPs] 1, 4, 7, and 18). Yet, similar to other SCZ candidate genes, studies have been inconsistent with respect to the associated alleles.nnnMETHODSnIn an effort to resolve the role for RGS4 in SCZ susceptibility, we undertook a genotype-based meta-analysis using both published and unpublished family-based and case-control samples (total n = 13,807).nnnRESULTSnThe family-based dataset consisted of 10 samples (2160 families). Significant associations with individual SNPs/haplotypes were not observed. In contrast, global analysis revealed significant transmission distortion (p = .0009). Specifically, analyses suggested overtransmission of two common haplotypes that account for the vast majority of all haplotypes. Separate analyses of 3486 cases and 3755 control samples (eight samples) detected a significant association with SNP 4 (p = .01). Individual haplotype analyses were not significant, but evaluation of test statistics from individual samples suggested significant associations.nnnCONCLUSIONSnOur collaborative meta-analysis represents one of the largest SCZ association studies to date. No individual risk factor arose from our analyses, but interpretation of these results is not straightforward. Our analyses suggest risk due to at least two common haplotypes in the presence of heterogeneity. Similar analysis for other putative susceptibility genes is warranted.


Genes, Brain and Behavior | 2004

Association and linkage analysis of RGS4 polymorphisms with schizophrenia and bipolar disorder in Brazil

Quirino Cordeiro; Michael E. Talkowski; Kodavali V. Chowdari; Joel Wood; Vishwajit L. Nimgaonkar; Homero Vallada

Linkage and association studies in five independently ascertained samples have suggested that polymorphisms of the regulator of G‐protein signaling 4 (RGS4) may confer risk for schizophrenia (SCZ). Suggestive evidence for association with bipolar disorder (BD) has also been presented. However, the associated alleles and haplotypes have differed among the samples. Data from other independent samples may clarify the putative associations. Hence, we investigated an independent, ethnically diverse Brazilian population comprising patients with SCZ (nu2003=u2003271) or BD1 (nu2003=u2003306), who were contrasted with 576 community‐based controls. Parents of 49 SCZ cases and 44 BD cases were available for transmission disequilibrium tests (TDTs). Four RGS4 single‐nucleotide polymorphisms (SNPs) 1, 4, 7 and 18 putatively associated with SCZ were investigated. In the SCZ samples, significant case–control differences were not observed for individual SNPs or haplotypes, though the TDT suggested transmission distortion similar to that observed in the initial report. For the BD sample, case–control comparisons revealed no significant differences for individual SNPs, but an omnibus test suggested differences in the overall distribution of haplotypes bearing all four SNPs (SNP‐EM Omnibus likelihood ratio test; Pu2003=u20030.003). The TDT revealed over‐transmission of allele A at SNP7 (Pu2003=u20030.016), as well as haplotypes incorporating this allele. However, global tests incorporating all haplotypes yielded only suggestive trends for association (Pu2003=u20030.19). In conclusion, association with SCZ was not detected in the present analyses. The failure to detect an association may be related to inadequate power or to confounds related to ethnic admixture. Suggestive associations with BD detected here require further investigation in a larger sample.


Biological Psychiatry | 2006

Novel, replicated associations between dopamine D3 receptor gene polymorphisms and schizophrenia in two independent samples.

Michael E. Talkowski; Hader Mansour; Kodavali V. Chowdari; Joel Wood; Allison Butler; Panchami G. Varma; Suman Prasad; Prachi Semwal; Triptish Bhatia; Smita N. Deshpande; Bernie Devlin; B.K. Thelma; Vishwajit L. Nimgaonkar

BACKGROUNDnMeta-analyses have suggested an association between schizophrenia (SZ) and a coding polymorphism (rs6280/Ser9Gly) at the dopamine D3 receptor gene (DRD3), but results have been inconsistent. Because most studies have evaluated only rs6280, the inconsistencies might reflect associations with other variants.nnnMETHODSnWe analyzed polymorphisms spanning 109kb in two independent samples (United States: 13 single nucleotide polymorphisms (SNPs), 331 cases, 151 trios, 274 control subjects; India: 11 SNPs, 141 trios).nnnRESULTSnIn the U.S. samples, significant associations were detected with eight SNPs, including rs6280 (p = .001, odds ratio: 1.5). Consistent associations in the case-control and family-based analyses were detected with a common haplotype spanning intron 1 to the 3 region of the gene (rs324029-rs7625282-rs324030-rs2134655-rs10934254; case-control, p = .002; transmission disequilibrium test [TDT], p = .0009; global p-values = .002 and .007, respectively). In the Indian sample, one SNP was associated (rs10934254, p = .03). Moreover, over-transmission of the same common haplotype as the U.S. sample was observed in this cohort (TDT, p = .005; global test, p = .009). Ser9Gly (rs6280) was associated with SZ against this haplotype background but not other haplotypes.nnnCONCLUSIONSnThese data suggest previous inconsistencies might have resulted from associations with other DRD3 variants. A liability locus might be in linkage disequilibrium (LD) with or carried against, an associated haplotype 3 to rs6280. Comprehensive SNP evaluation in larger samples is needed.


Schizophrenia Bulletin | 2010

RGS4 Polymorphisms Associated With Variability of Cognitive Performance in a Family-Based Schizophrenia Sample

Konasale M. Prasad; Laura Almasy; Ruben C. Gur; Raquel E. Gur; Michael F. Pogue-Geile; Kodavali V. Chowdari; Michael E. Talkowski; Vishwajit L. Nimgaonkar

Polymorphisms of the gene encoding the regulator of G protein signaling, subtype 4 (RGS4), may be associated with schizophrenia. Among first-episode schizophrenia patients, they are also associated with dorsolateral prefrontal cortex (DLPFC) volume. The DLPFC is a key region that regulates heritable cognitive functions implicated in schizophrenia pathogenesis. To further understand the relationship of RGS4 variants to schizophrenia, we examined their associations with cognitive functions among schizophrenia patients and their relatives. We analyzed 31 multiplex, multigenerational Caucasian families with schizophrenia recruited on the basis of 2 affected first-degree relatives. All participants underwent a computerized neurocognitive battery that evaluates accuracy and speed (response time) of performance on abstraction/mental flexibility; attention; verbal, spatial, and face memory; and spatial ability. Tag single-nucleotide polymorphisms (SNPs) representing common polymorphisms were genotyped. Measured genotype analyses accounting for family relationships were performed using Sequential Oligogenic Linkage Analysis Routines. SNPs rs10917670 (SNP1) and rs951439 (SNP7) were associated with face memory speed (P = .0003) at a significance level that survived Bonferroni correction (P = .039). The same SNPs have earlier been reported to be associated with schizophrenia. There also were uncorrected associations with rs10917670 (SNP1) and rs951439 (SNP7) on face memory efficiency (P = .03) and verbal memory efficiency (P = 0.02), rs28757217 on abstraction/mental flexibility speed (P = .02) and verbal memory efficiency (P = .03), SNP18 (rs2661319) on spatial memory accuracy (P = 0.02) and face memory speed (P = .03). RGS4 polymorphisms are associated with variations in cognitive functions and contribute a small but statistically significant proportion of variance in a family-based sample.


American Journal of Medical Genetics | 2010

Fine-mapping reveals novel alternative splicing of the dopamine transporter

Michael E. Talkowski; Kathleen L. McCann; Michael Chen; Lora McClain; Mikhil Bamne; Joel Wood; Kodavali V. Chowdari; Annie M. Watson; Konasale M. Prasad; George Kirov; Lyudmila Georgieva; Draga Toncheva; Hader Mansour; David A. Lewis; Michael John Owen; Michael Conlon O'Donovan; Panagiotis Papasaikas; Patrick F. Sullivan; Douglas M. Ruderfer; Jeffrey K. Yao; Sherry Leonard; Pramod Thomas; Fabio Miyajima; John P. Quinn; A. Javier Lopez; Vishwajit L. Nimgaonkar

The dopamine transporter gene (SLC6A3, DAT) has been implicated in the pathogenesis of numerous psychiatric and neurodevelopmental disorders, including schizophrenia (SZ). We previously detected association between SZ and intronic SLC6A3 variants that replicated in two independent Caucasian samples, but had no obvious function. In follow‐up analyses, we sequenced the coding and intronic regions of SLC6A3 to identify complete linkage disequilibrium patterns of common variations. We genotyped 78 polymorphisms, narrowing the potentially causal region to two correlated clusters of associated SNPs localized predominantly to introns 3 and 4. Our computational analysis of these intronic regions predicted a novel cassette exon within intron 3, designated E3b, which is conserved among primates. We confirmed alternative splicing of E3b in post‐mortem human substantia nigra (SN). As E3b introduces multiple in‐frame stop codons, the SLC6A3 open reading frame is truncated and the spliced product may undergo nonsense mediated decay. Thus, factors that increase E3b splicing could reduce the amount of unspliced product available for translation. Observations consistent with this prediction were made using cellular assays and in post‐mortem human SN. In mini‐gene constructs, the extent of splicing is also influenced by at least two common haplotypes, so the alternative splicing was evaluated in relation to SZ risk. Meta‐analyses across genome‐wide association studies did not support the initial associations and further post‐mortem studies did not suggest case‐control differences in splicing. These studies do not provide a compelling link to schizophrenia. However, the impact of the alternative splicing on other neuropsychiatric disorders should be investigated.


American Journal of Medical Genetics | 2009

Convergent patterns of association between phenylalanine hydroxylase variants and schizophrenia in four independent samples

Michael E. Talkowski; Lora McClain; Trina B. Allen; L. DiAnne Bradford; Monica E. Calkins; Neil B. Edwards; Lyudmila Georgieva; Rodney C.P. Go; Ruben C. Gur; Raquel E. Gur; George Kirov; Kodavali V. Chowdari; Joseph Kwentus; Paul D. Lyons; Hader Mansour; Joseph P. McEvoy; Michael Conlon O'Donovan; Judith R. O'Jile; Michael John Owen; Alberto B. Santos; Robert M. Savage; Draga Toncheva; Gerard Vockley; Joel Wood; Bernie Devlin; Vishwajit L. Nimgaonkar

Recessive mutations in the phenylalanine hydroxylase (PAH) gene predispose to phenylketonuria (PKU) in conjunction with dietary exposure to phenylalanine. Previous studies have suggested PAH variations could confer risk for schizophrenia, but comprehensive follow‐up has not been reported. We analyzed 15 common PAH “tag” SNPs and three exonic variations that are rare in Caucasians but common in African‐Americans among four independent samples (total nu2009=u20095,414). The samples included two US Caucasian cohorts (260 trios, 230 independent cases, 474 controls), Bulgarian families (659 trios), and an African‐American sample (464 families, 401 controls). Analyses of both US Caucasian samples revealed associations with five SNPs; most notably the common allele (G) of rs1522305 from case–control analyses (zu2009=u20092.99, Pu2009=u20090.006). This SNP was independently replicated in the Bulgarian cohort (zu2009=u20092.39, Pu2009=u20090.015). A non‐significant trend was also observed among African‐American families (zu2009=u20091.39, Pu2009=u20090.165), and combined analyses of all four samples were significant (rs1522305: χ2u2009=u200923.28, 8 d.f., Pu2009=u20090.003). Results for rs1522305 met our a priori criteria for statistical significance, namely an association that was robust to multiple testing correction in one sample, a replicated risk allele in multiple samples, and combined analyses that were nominally significant. Case–control results in African‐Americans detected an association with L321L (Pu2009=u20090.047, ORu2009=u20091.46). Our analyses suggest several associations at PAH, with consistent evidence for rs1522305. Further analyses, including additional variations and environmental influences such as phenylalanine exposure are warranted.


Human Molecular Genetics | 2008

A network of dopaminergic gene variations implicated as risk factors for schizophrenia

Michael E. Talkowski; George Kirov; Mikhil Bamne; Lyudmila Georgieva; Gonzalo E. Torres; Hader Mansour; Kodavali V. Chowdari; Vihra Milanova; Joel Wood; Lora McClain; Konasale M. Prasad; Brian H. Shirts; Jianping Zhang; Michael C. O’Donovan; Michael John Owen; Bernie Devlin; Vishwajit L. Nimgaonkar


Schizophrenia Bulletin | 2007

Linkage Disequilibrium Patterns and Functional Analysis of RGS4 Polymorphisms in Relation to Schizophrenia

Kodavali V. Chowdari; Mikhil Bamne; Joel Wood; Michael E. Talkowski; Karoly Mirnics; Pat Levitt; David A. Lewis; Vishwajit L. Nimgaonkar

Collaboration


Dive into the Vishwajit L. Nimgaonkar's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Joel Wood

University of Pittsburgh

View shared research outputs
Top Co-Authors

Avatar

David A. Lewis

University of Pittsburgh

View shared research outputs
Top Co-Authors

Avatar

Hader Mansour

University of Pittsburgh

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Lora McClain

University of Pittsburgh

View shared research outputs
Top Co-Authors

Avatar

Bernie Devlin

University of Pittsburgh

View shared research outputs
Top Co-Authors

Avatar

Mikhil Bamne

University of Pittsburgh

View shared research outputs
Top Co-Authors

Avatar

Pat Levitt

Children's Hospital Los Angeles

View shared research outputs
Researchain Logo
Decentralizing Knowledge